SGLT-2 Inhibitor Pharmaceutical Composition for Diabetes Treatment
Summary
The USPTO published patent application US20260097058A1 for a pharmaceutical composition containing SGLT-2 inhibitors for treating diabetes mellitus, impaired glucose tolerance, hyperglycemia, and metabolic disorders. Inventors include Peter Eickelmann, Michael Mark, Leo John Seman, Leo Thomas, Uli Christian Broedl, and Rolf Grempler. The application was filed on December 11, 2025.
What changed
The USPTO published a patent application for a pharmaceutical composition using SGLT-2 inhibitors to treat diabetes mellitus (types 1 and 2), impaired glucose tolerance, hyperglycemia, and related metabolic disorders. The application covers methods for treatment and prevention using the disclosed composition.
Affected parties including pharmaceutical companies, drug developers, and healthcare providers should monitor this application for potential patent claims that may affect future diabetes treatments using SGLT-2 inhibitors. The published application establishes priority dates and defines the scope of intellectual property protection sought for the disclosed invention.
What to do next
- Monitor application status for patent issuance
Archived snapshot
Apr 12, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
Application US20260097058A1 Kind: A1 Apr 09, 2026
Inventors
Peter EICKELMANN, Michael Mark, Leo John Seman, Leo Thomas, Uli Christian Broedl, Rolf Grempler
Abstract
The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
CPC Classifications
A61K 31/7034 A61K 31/7048
Filing Date
2025-12-11
Application No.
19415956
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.